References
- 1. FATOURECHI V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc. 2009; 84(1):65-71.
- 2. WIERSINGA WM. Guidance in subclinical hyperthyroidism and subclinical hypothyroidism: are we making progress? Eur Thyroid J. 2015; 4(3):143-8.
- 3. MALEKI N., KAZEROUNI F., HEDAYATI M., RAHIMIPOUR A., PARHAM M. Subclinical hypothyroidism and the alterations of lipid profile as a cardiovascular risk factor. J Paramed Sci. 2015; 6(4):2008-4978.
- 4. RIZOS CV., ELISAF MS., LIBEROPOULUS EN. Effects of thyroid dysfunction on lipid profile, Open Cardiovasc Med J. 2011; 5:76-84.
- 5. VANDERMEERSCH A., AMEYE S., PUYPE D., PETITJEAN D., De BUYZERE M., LANGLOIS MR. Estimation of the lowdensity lipoprotein (LDL) subclass phenotype using a direct, automated assay of small dense LDL-cholesterol without sample pretreatment. Clin Chim Acta. 2010; 411(17-18):1361-66.
- 6. NATIONAL CHOLESTEROL EDUCATION PROGRAM (NCEP) EXPERT PANEL ON DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD CHOLESTEROL IN ADULTS (Adult Treatment Panel III), Third report of the National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation. 2002; 106(25):3143-3421.
- 7. AUSTIN MA., BRESLOW JL., HENNEKENS CH., BURING JE., WILLETT WC., KRAUSS RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988; 260(13):1917-21.
- 8. CARMENA R., DURIEZ P., FRUCHART JC. Atherogenic lipoprotein particles in atherosclerosis. Circulation. 2004; 109 (23 Suppl 1):III2-7.
- 9. BERNEIS KK., KRAUSSS RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002; 43(9):1363-79.
- 10. LAMARCHE B., TCHERNOF A., MOORJANI S., CANTIN B., DAGENAIS GR., LUPIEN PJ., et al. Small, dense LDL particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation. 1997; 95(1):69-75.
- 11. VERHOYE E., LANGLOIS MR., ASKLEPIOS INVESTIGATORS. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk? Clin Chem Lab Med. 2009; 47(2):128-37.
- 12. TOGNINI S., POLINI A., PASAQUALETTI G., URSINO S., CARACCIO N., ERDEGHINI M., et al. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study. Thyroid. 2012; 22(11):1096-103.
- 13. HAK AE., POLS HA., VISSER TJ., DREXHAGE HA., HOFMAN A., WITTEMAN JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000; 132(4):270-8.
- 14. WALSH JP., BREMNER AP., BULSARA MK., O’LEARY P., LEEDMAN PJ., FEDDEMA P., et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005; 165(21):2467-72.
- 15. COOPER DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med. 2001; 345(4):260-5.
- 16. KLEIN I. Subclinical hypothyroidism - just a high serum thyrotropin concentration or something else? J Clin Endocrinol Metab. 2013; 98(2):508-10.
- 17. DUNTAS LH., BRENTA G. The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am. 2012; 96(2):269-81.
- 18. PEARCE EN. Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab. 2012; 97(2):326-33.
- 19. BOEKHOLDT SM., TITAN SM., WIERSINGA WM., CHATTERJEE K., BASART DC., LUBEN R., et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf). 2010; 72(3):404-10.
- 20. WORLD HEALTH ORGANIZATION. “BMI Classification”. Global Database on Body Mass Index. 2006.
- 21. KUSIC Z., JUKIC T., FRANCESCHI M., DEBELIC N., RONCEVIC S., LUKINAC L. Croatian Thyroid Society guidelines for rational detection of thyroid dysfunction. Lijec Vjesn. 2009; 131(11-12):328-38.
- 22. LUBOSHITZKY R., AVIV A., HERER P., LAVIE L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid. 2002; 12(5):421-5.
- 23. KARTHICK N., DILLARA K., POORNIMA KN., SBHASINI AS. Dyslipidaemic changes in women with subclinical hypothyroidism. J Clin Diagn Res. 2013; 7(10):2122-5.
- 24. TOURNER F., ALTINOVA AE., KARAKOC A., YETKIN I., AYVAZ G., CAKIR N., et al. Risk factors for cardiovascular disease in patients with subclinical hypothyroidism. Adv Ther. 2008; 25(5):430-7.
- 25. PEARCE SH., BRABANT G., DUNTAS LH., MONZANI F., PEETERS RP., RAZVI S., et al. 2013 ETA Guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013; 2(4):215-28.
- 26. ABBAS JM., CHAKRABORTY J., AKANJI AO., DOI SA. Hypothyroidism results in small dense LDL independent of IRS traits and hypertriglyceridemia. Endocr J. 2008; 55(2):381-9.
- 27. RAZVI S., WEAVER JU., VANDERPUMP MP, PEARCE SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: re-analysis of the Whickham Survey cohort. J Clin Endocrinol Metab 2010; 95:1734-40.
- 28. CAPPOLA AR., FRIED LP., ARNOLD AM., DANESE MD., KULLER LH., BURKE GL., et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006; 295(9):1033-41.
- 29. LAM KS., CHAN MK., YEUNG RT. High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction-effects of treatment. Q J Med. 1986; 59(229):513-521.
- 30. PEARCE EN., WILSON PW., YANG Q., VASAN RS., BRAVERMAN LE. Thyroid function and lipid subparticle sizes in patients with short-term hypothyroidism and a population-based cohort. J Clin Endocrinol Metab. 2008; 93(3):888-94.